Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,961 | -16,381 | -45,903 | -31,706 | -14,589 |
| Depreciation Amortization | 456 | 224 | 12 | 12 | 6 |
| Income taxes - deferred | N/A | N/A | 66 | 63 | N/A |
| Accounts payable and accrued liabilities | 4,291 | 3,920 | -2,023 | -1,908 | -1,572 |
| Other Working Capital | 7,968 | 5,225 | -1,176 | -3,472 | -6,445 |
| Other Operating Activity | -2,823 | -3,480 | 4,325 | 3,840 | 3,155 |
| Operating Cash Flow | $-31,069 | $-10,491 | $-44,699 | $-33,171 | $-19,445 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,080 | -941 | -8,802 | -6,320 | -3,242 |
| Purchase Of Investment | -126,563 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-129,643 | $-941 | $-8,802 | $-6,320 | $-3,242 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,563 | -3,563 | N/A |
| Common Stock Issued | 4 | 1 | 285,333 | 285,333 | 285,877 |
| Financing Cash Flow | $4 | $1 | $281,770 | $281,770 | $285,877 |
| Beginning Cash Position | 238,816 | 238,816 | 10,547 | 10,547 | 10,547 |
| End Cash Position | 78,108 | 227,385 | 238,816 | 252,826 | 273,737 |
| Net Cash Flow | $-160,708 | $-11,431 | $228,269 | $242,279 | $263,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,069 | -10,491 | -44,699 | -33,171 | -19,445 |
| Capital Expenditure | -3,080 | -941 | -8,802 | -6,320 | -3,242 |
| Free Cash Flow | -34,149 | -11,432 | -53,501 | -39,491 | -22,687 |